Administrative Investigation VA Secretary and Delegation Travel to Europe

whitePaper | February 12, 2020

Both the U.S. Government and biopharmaceutical industry have been central engines for developing new medical treatments and cures, thereby lowering the effective price of better health for patients worldwide. The sector has done so by being both the world leader in these biopharmaceutical cures and treatments as well as the source of the returns that are required to fund new medical R&D investments.

whitePaper | November 15, 2019

Trade was not such a controversial topic not so long ago. For most of the post-war era trade worked well for the US and for many other countries. A bipartisan consensus supported continuing trade liberalization as long as it was accompanied by full employment. However trade always had winners and losers as economies adjust to different costs of production among trading partners and over the last few decades the number of US workers losing from trade mounted and the losses spread across hard hit communities. For these and other reasons, trade has become so controversial that it is now a key pivot point in politics and elections in the US.

whitePaper | March 3, 2023

Budget of the United States Government, Fiscal Year 2024 contains the Budget Message of the President, information on the President’s priorities, and summary tables. Analytical Perspectives, Budget of the United States Government, Fiscal Year 2024 contains analyses that are designed to highlight specified subject areas or provide other significant presentations of budget data that place the budget in perspective. This volume includes economic and accounting analyses, information on Federal receipts and collections, analyses of Federal spending, information on Federal borrowing and debt, baseline or current services estimates, and other technical presentations.

whitePaper | December 10, 2019

The Trump administration, members of Congress from both parties, and many states have introduced proposals to combat high drug prices. Too often missing from these reform efforts, however, is a clear understanding of a root cause of the crisis: the suppression of fair market competition through various forms of monopoly. This white paper examines and proposes solutions for the two main ways that monopoly drives up the costs and lowers the quality of prescription drugs: increasing corporate concentration in the pharmaceutical industry, and the monopoly markets for individual drugs created by a deeply flawed and increasingly abused patent and regulatory system.

whitePaper | May 1, 2022

Customer experience (CX) in government is about more than any single web form, survey, portal, or online claims submission. CX also considers the perceptions, preferences, and sentiments for an individual, business, or organization as they interact across the various channels of an agency’s program or service.

whitePaper | December 27, 2021

Government Financial & Operational Management Special Report Identifying the challenges that face your governmental entity is oftentimes the first step in helping position your government for future success. Are you able to balance the needs of your community while efficiently managing and reporting on the services you’re charged with providing?